Clinical Trial Update: A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluated GEMOX with or without cetuximab in locally advanced and metastatic biliary tract cancers, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of Gallbladder
• Cholangiocarcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Cholangiocarcinoma, Adenocarcinoma of Gallbladder | Phase 2 | Status: COMPLETED